Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 4Completed 4Terminated 3Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Gastrointestinal 8Breast 6Genitourinary 5CNS 4Thoracic 3Gynecologic 3Dermatologic 3Tumor-Agnostic 2Head & Neck 2

Conditions

Uveal Melanoma 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Ovarian Neoplasms 1Lung Neoplasms 1Esophageal Neoplasms 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 58Ipilimumab 53Cyclophosphamide 53Nivolumab 45aldesleukin 35Interleukin-2 26fludarabine phosphate 22fludarabine 21Vemurafenib 20Temozolomide 19Radiotherapy 19dabrafenib 15trametinib 12Radiosurgery 11CTLA-4 Antigen 11spartalizumab 10Filgrastim 10Dacarbazine 10cobimetinib 9binimetinib 9atezolizumab 9Biopsy 9poly ICLC 8Paclitaxel 8Antilymphocyte Serum 8encorafenib 7avelumab 7Rituximab 7Introns 7romidepsin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Standard of Care × Dermatologic × Clear all
NCT05110924 2024-12-17

BASINEL

University Hospital, Ghent

Phase NA Terminated
9 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT05266430 2023-08-09

IL

Aura Biosciences

Terminated
2 enrolled
Dermatologic

Uveal Melanoma

NCT01010334 2013-08-14

Comparison of Standard of Care or Treatment on Protocol

New Mexico Cancer Research Alliance

Phase NA Terminated
13 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Skin Neoplasms, Stomach Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡